ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global mRNA Vaccine Core Enzyme Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-23Z13774
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global mRNA Vaccine Core Enzyme Market Research Report 2023
BUY CHAPTERS

Global mRNA Vaccine Core Enzyme Market Research Report 2025

Code: QYRE-Auto-23Z13774
Report
March 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
NEB
Yeasen Biotechnology
Aldevron
Takara Bio Inc
TriLink Bio Technologies
Promega
Thermo Fisher
Merck
QIAGEN N V
Roche CustomBiotech
Novoprotein
Vazyme
Hongene Biotech Corporatio

mRNA Vaccine Core Enzyme Market Size

The global market for mRNA Vaccine Core Enzyme was valued at US$ 2008 million in the year 2024 and is projected to reach a revised size of US$ 1687 million by 2031, growing at a CAGR of -2.5% during the forecast period.

mRNA Vaccine Core Enzyme Market

mRNA Vaccine Core Enzyme Market

mRNA-vaccines can efficiently activate both components of the immune system, i.e., T-cell and humoral responses. The essential advantage of mRNA vaccines includes fast, inexpensive, scalable and uniform production providing a large output of desirable products in vitro. Synthesis and purification processes significantly simplify the process technology of mRNA drugs with injectable purity. Thus, mRNA production via in vitro transcription is more advantageous as compared with DNA-vaccines since it is a chemical process without the use of cells. mRNA techniques make it possible to pass all the phases of vaccine development much faster in comparison with the production of vaccines based on inactivated viruses or recombinant proteins. This property is critically important when designing vaccines against viral pathogens as the main problem of disease control includes a time gap between an epidemic and vaccine development. mRNA vaccine core enzyme is the key raw material in the production of mRNA vaccine and drugs.
The core manufacturers of mRNA Vaccine Core Enzyme mainly include Thermo Fisher, NEB, TriLink Bio Technologies, Merck, etc. The top four companies in the industry account for about 49% of the market. North America is the largest market, accounting for about 38% of the global market share. In terms of product type, Capping Enzyme have the largest market share of about 25%. From an application perspective, Biopharmaceutical Companies account for the largest share at around 84%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for mRNA Vaccine Core Enzyme, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Vaccine Core Enzyme.
The mRNA Vaccine Core Enzyme market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global mRNA Vaccine Core Enzyme market comprehensively. Regional market sizes, concerning products by Enzyme Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Vaccine Core Enzyme manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Enzyme Type, by Application, and by regions.

Scope of mRNA Vaccine Core Enzyme Market Report

Report Metric Details
Report Name mRNA Vaccine Core Enzyme Market
Accounted market size in year US$ 2008 million
Forecasted market size in 2031 US$ 1687 million
Base Year year
Forecasted years 2025 - 2031
Segment by Enzyme Type
  • Capping Enzyme
  • 2'-O-Methyltransferase
  • Inorganic Pyrophosphatase
  • Poly (A) Polymerase
  • Rnase Inhibitor
  • RNA Polymerase
  • Restriction Enzyme
  • Dnase I
  • Others
Segment by Application
  • Biopharmaceutical Companies
  • Academic and Research Institutions
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Thermo Fisher, NEB, TriLink Bio Technologies, Merck, Aldevron, Qiagen N.V., Promega, Roche CustomBiotech, Takara Bio Inc., Novoprotein, Vazyme, Hongene Biotech Corporatio, Yeasen Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of mRNA Vaccine Core Enzyme manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of mRNA Vaccine Core Enzyme in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Enzyme Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

What is the mRNA Vaccine Core Enzyme Market size in 2031?

Ans: The mRNA Vaccine Core Enzyme Market size in 2031 will be US$ 1687 million.

What is the market share of major companies in mRNA Vaccine Core Enzyme Market?

Ans: The top four companies in the industry account for about 49% of the market.

What is the mRNA Vaccine Core Enzyme Market share by region?

Ans: North America is the largest market, accounting for about 38% of the global market share.

What is the mRNA Vaccine Core Enzyme Market share by type?

Ans: In terms of product type, Capping Enzyme have the largest market share of about 25%.

What is the mRNA Vaccine Core Enzyme Market share by application?

Ans: From an application perspective, Biopharmaceutical Companies account for the largest share at around 84%.

Who are the main players in the mRNA Vaccine Core Enzyme Market report?

Ans: The main players in the mRNA Vaccine Core Enzyme Market are Thermo Fisher, NEB, TriLink Bio Technologies, Merck, Aldevron, Qiagen N.V., Promega, Roche CustomBiotech, Takara Bio Inc., Novoprotein, Vazyme, Hongene Biotech Corporatio, Yeasen Biotechnology

What are the Application segmentation covered in the mRNA Vaccine Core Enzyme Market report?

Ans: The Applications covered in the mRNA Vaccine Core Enzyme Market report are Biopharmaceutical Companies, Academic and Research Institutions

What are the Type segmentation covered in the mRNA Vaccine Core Enzyme Market report?

Ans: The Types covered in the mRNA Vaccine Core Enzyme Market report are Capping Enzyme, 2'-O-Methyltransferase, Inorganic Pyrophosphatase, Poly (A) Polymerase, Rnase Inhibitor, RNA Polymerase, Restriction Enzyme, Dnase I, Others

Recommended Reports

Vaccine Technologies

Vaccine Equipment

Market Segments

1 mRNA Vaccine Core Enzyme Market Overview
1.1 Product Definition
1.2 mRNA Vaccine Core Enzyme by Enzyme Type
1.2.1 Global mRNA Vaccine Core Enzyme Market Value Comparison by Enzyme Type (2024 VS 2031)
1.2.2 Capping Enzyme
1.2.3 2'-O-Methyltransferase
1.2.4 Inorganic Pyrophosphatase
1.2.5 Poly (A) Polymerase
1.2.6 Rnase Inhibitor
1.2.7 RNA Polymerase
1.2.8 Restriction Enzyme
1.2.9 Dnase I
1.2.10 Others
1.3 mRNA Vaccine Core Enzyme by Application
1.3.1 Global mRNA Vaccine Core Enzyme Market Value by Application (2024 VS 2031)
1.3.2 Biopharmaceutical Companies
1.3.3 Academic and Research Institutions
1.4 Global mRNA Vaccine Core Enzyme Market Size Estimates and Forecasts
1.4.1 Global mRNA Vaccine Core Enzyme Revenue 2020-2031
1.4.2 Global mRNA Vaccine Core Enzyme Sales 2020-2031
1.4.3 Global mRNA Vaccine Core Enzyme Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 mRNA Vaccine Core Enzyme Market Competition by Manufacturers
2.1 Global mRNA Vaccine Core Enzyme Sales Market Share by Manufacturers (2020-2025)
2.2 Global mRNA Vaccine Core Enzyme Revenue Market Share by Manufacturers (2020-2025)
2.3 Global mRNA Vaccine Core Enzyme Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of mRNA Vaccine Core Enzyme, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of mRNA Vaccine Core Enzyme, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of mRNA Vaccine Core Enzyme, Product Type & Application
2.7 Global Key Manufacturers of mRNA Vaccine Core Enzyme, Date of Enter into This Industry
2.8 Global mRNA Vaccine Core Enzyme Market Competitive Situation and Trends
2.8.1 Global mRNA Vaccine Core Enzyme Market Concentration Rate
2.8.2 The Global 5 and 10 Largest mRNA Vaccine Core Enzyme Players Market Share by Revenue
2.8.3 Global mRNA Vaccine Core Enzyme Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global mRNA Vaccine Core Enzyme Market Scenario by Region
3.1 Global mRNA Vaccine Core Enzyme Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global mRNA Vaccine Core Enzyme Sales by Region: 2020-2031
3.2.1 Global mRNA Vaccine Core Enzyme Sales by Region: 2020-2025
3.2.2 Global mRNA Vaccine Core Enzyme Sales by Region: 2026-2031
3.3 Global mRNA Vaccine Core Enzyme Revenue by Region: 2020-2031
3.3.1 Global mRNA Vaccine Core Enzyme Revenue by Region: 2020-2025
3.3.2 Global mRNA Vaccine Core Enzyme Revenue by Region: 2026-2031
3.4 North America mRNA Vaccine Core Enzyme Market Facts & Figures by Country
3.4.1 North America mRNA Vaccine Core Enzyme Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America mRNA Vaccine Core Enzyme Sales by Country (2020-2031)
3.4.3 North America mRNA Vaccine Core Enzyme Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe mRNA Vaccine Core Enzyme Market Facts & Figures by Country
3.5.1 Europe mRNA Vaccine Core Enzyme Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe mRNA Vaccine Core Enzyme Sales by Country (2020-2031)
3.5.3 Europe mRNA Vaccine Core Enzyme Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific mRNA Vaccine Core Enzyme Market Facts & Figures by Region
3.6.1 Asia Pacific mRNA Vaccine Core Enzyme Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific mRNA Vaccine Core Enzyme Sales by Region (2020-2031)
3.6.3 Asia Pacific mRNA Vaccine Core Enzyme Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America mRNA Vaccine Core Enzyme Market Facts & Figures by Country
3.7.1 Latin America mRNA Vaccine Core Enzyme Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America mRNA Vaccine Core Enzyme Sales by Country (2020-2031)
3.7.3 Latin America mRNA Vaccine Core Enzyme Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa mRNA Vaccine Core Enzyme Market Facts & Figures by Country
3.8.1 Middle East and Africa mRNA Vaccine Core Enzyme Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa mRNA Vaccine Core Enzyme Sales by Country (2020-2031)
3.8.3 Middle East and Africa mRNA Vaccine Core Enzyme Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Enzyme Type
4.1 Global mRNA Vaccine Core Enzyme Sales by Enzyme Type (2020-2031)
4.1.1 Global mRNA Vaccine Core Enzyme Sales by Enzyme Type (2020-2025)
4.1.2 Global mRNA Vaccine Core Enzyme Sales by Enzyme Type (2026-2031)
4.1.3 Global mRNA Vaccine Core Enzyme Sales Market Share by Enzyme Type (2020-2031)
4.2 Global mRNA Vaccine Core Enzyme Revenue by Enzyme Type (2020-2031)
4.2.1 Global mRNA Vaccine Core Enzyme Revenue by Enzyme Type (2020-2025)
4.2.2 Global mRNA Vaccine Core Enzyme Revenue by Enzyme Type (2026-2031)
4.2.3 Global mRNA Vaccine Core Enzyme Revenue Market Share by Enzyme Type (2020-2031)
4.3 Global mRNA Vaccine Core Enzyme Price by Enzyme Type (2020-2031)
5 Segment by Application
5.1 Global mRNA Vaccine Core Enzyme Sales by Application (2020-2031)
5.1.1 Global mRNA Vaccine Core Enzyme Sales by Application (2020-2025)
5.1.2 Global mRNA Vaccine Core Enzyme Sales by Application (2026-2031)
5.1.3 Global mRNA Vaccine Core Enzyme Sales Market Share by Application (2020-2031)
5.2 Global mRNA Vaccine Core Enzyme Revenue by Application (2020-2031)
5.2.1 Global mRNA Vaccine Core Enzyme Revenue by Application (2020-2025)
5.2.2 Global mRNA Vaccine Core Enzyme Revenue by Application (2026-2031)
5.2.3 Global mRNA Vaccine Core Enzyme Revenue Market Share by Application (2020-2031)
5.3 Global mRNA Vaccine Core Enzyme Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Thermo Fisher
6.1.1 Thermo Fisher Company Information
6.1.2 Thermo Fisher Description and Business Overview
6.1.3 Thermo Fisher mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Thermo Fisher mRNA Vaccine Core Enzyme Product Portfolio
6.1.5 Thermo Fisher Recent Developments/Updates
6.2 NEB
6.2.1 NEB Company Information
6.2.2 NEB Description and Business Overview
6.2.3 NEB mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2020-2025)
6.2.4 NEB mRNA Vaccine Core Enzyme Product Portfolio
6.2.5 NEB Recent Developments/Updates
6.3 TriLink Bio Technologies
6.3.1 TriLink Bio Technologies Company Information
6.3.2 TriLink Bio Technologies Description and Business Overview
6.3.3 TriLink Bio Technologies mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2020-2025)
6.3.4 TriLink Bio Technologies mRNA Vaccine Core Enzyme Product Portfolio
6.3.5 TriLink Bio Technologies Recent Developments/Updates
6.4 Merck
6.4.1 Merck Company Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Merck mRNA Vaccine Core Enzyme Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Aldevron
6.5.1 Aldevron Company Information
6.5.2 Aldevron Description and Business Overview
6.5.3 Aldevron mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Aldevron mRNA Vaccine Core Enzyme Product Portfolio
6.5.5 Aldevron Recent Developments/Updates
6.6 Qiagen N.V.
6.6.1 Qiagen N.V. Company Information
6.6.2 Qiagen N.V. Description and Business Overview
6.6.3 Qiagen N.V. mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Qiagen N.V. mRNA Vaccine Core Enzyme Product Portfolio
6.6.5 Qiagen N.V. Recent Developments/Updates
6.7 Promega
6.7.1 Promega Company Information
6.7.2 Promega Description and Business Overview
6.7.3 Promega mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Promega mRNA Vaccine Core Enzyme Product Portfolio
6.7.5 Promega Recent Developments/Updates
6.8 Roche CustomBiotech
6.8.1 Roche CustomBiotech Company Information
6.8.2 Roche CustomBiotech Description and Business Overview
6.8.3 Roche CustomBiotech mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Roche CustomBiotech mRNA Vaccine Core Enzyme Product Portfolio
6.8.5 Roche CustomBiotech Recent Developments/Updates
6.9 Takara Bio Inc.
6.9.1 Takara Bio Inc. Company Information
6.9.2 Takara Bio Inc. Description and Business Overview
6.9.3 Takara Bio Inc. mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Takara Bio Inc. mRNA Vaccine Core Enzyme Product Portfolio
6.9.5 Takara Bio Inc. Recent Developments/Updates
6.10 Novoprotein
6.10.1 Novoprotein Company Information
6.10.2 Novoprotein Description and Business Overview
6.10.3 Novoprotein mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Novoprotein mRNA Vaccine Core Enzyme Product Portfolio
6.10.5 Novoprotein Recent Developments/Updates
6.11 Vazyme
6.11.1 Vazyme Company Information
6.11.2 Vazyme Description and Business Overview
6.11.3 Vazyme mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Vazyme mRNA Vaccine Core Enzyme Product Portfolio
6.11.5 Vazyme Recent Developments/Updates
6.12 Hongene Biotech Corporatio
6.12.1 Hongene Biotech Corporatio Company Information
6.12.2 Hongene Biotech Corporatio Description and Business Overview
6.12.3 Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Product Portfolio
6.12.5 Hongene Biotech Corporatio Recent Developments/Updates
6.13 Yeasen Biotechnology
6.13.1 Yeasen Biotechnology Company Information
6.13.2 Yeasen Biotechnology Description and Business Overview
6.13.3 Yeasen Biotechnology mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Yeasen Biotechnology mRNA Vaccine Core Enzyme Product Portfolio
6.13.5 Yeasen Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 mRNA Vaccine Core Enzyme Industry Chain Analysis
7.2 mRNA Vaccine Core Enzyme Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 mRNA Vaccine Core Enzyme Production Mode & Process Analysis
7.4 mRNA Vaccine Core Enzyme Sales and Marketing
7.4.1 mRNA Vaccine Core Enzyme Sales Channels
7.4.2 mRNA Vaccine Core Enzyme Distributors
7.5 mRNA Vaccine Core Enzyme Customer Analysis
8 mRNA Vaccine Core Enzyme Market Dynamics
8.1 mRNA Vaccine Core Enzyme Industry Trends
8.2 mRNA Vaccine Core Enzyme Market Drivers
8.3 mRNA Vaccine Core Enzyme Market Challenges
8.4 mRNA Vaccine Core Enzyme Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
NEB
Yeasen Biotechnology
Aldevron
Takara Bio Inc
TriLink Bio Technologies
Promega
Thermo Fisher
Merck
QIAGEN N V
Roche CustomBiotech
Novoprotein
Vazyme
Hongene Biotech Corporatio
List of Tables
 Table 1. Global mRNA Vaccine Core Enzyme Market Value Comparison by Enzyme Type (2024 VS 2031) & (US$ Million)
 Table 2. Global mRNA Vaccine Core Enzyme Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global mRNA Vaccine Core Enzyme Market Competitive Situation by Manufacturers in 2024
 Table 4. Global mRNA Vaccine Core Enzyme Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global mRNA Vaccine Core Enzyme Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global mRNA Vaccine Core Enzyme Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global mRNA Vaccine Core Enzyme Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market mRNA Vaccine Core Enzyme Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of mRNA Vaccine Core Enzyme, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of mRNA Vaccine Core Enzyme, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of mRNA Vaccine Core Enzyme, Product Type & Application
 Table 12. Global Key Manufacturers of mRNA Vaccine Core Enzyme, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global mRNA Vaccine Core Enzyme by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccine Core Enzyme as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global mRNA Vaccine Core Enzyme Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global mRNA Vaccine Core Enzyme Sales by Region (2020-2025) & (K Units)
 Table 18. Global mRNA Vaccine Core Enzyme Sales Market Share by Region (2020-2025)
 Table 19. Global mRNA Vaccine Core Enzyme Sales by Region (2026-2031) & (K Units)
 Table 20. Global mRNA Vaccine Core Enzyme Sales Market Share by Region (2026-2031)
 Table 21. Global mRNA Vaccine Core Enzyme Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global mRNA Vaccine Core Enzyme Revenue Market Share by Region (2020-2025)
 Table 23. Global mRNA Vaccine Core Enzyme Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global mRNA Vaccine Core Enzyme Revenue Market Share by Region (2026-2031)
 Table 25. North America mRNA Vaccine Core Enzyme Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America mRNA Vaccine Core Enzyme Sales by Country (2020-2025) & (K Units)
 Table 27. North America mRNA Vaccine Core Enzyme Sales by Country (2026-2031) & (K Units)
 Table 28. North America mRNA Vaccine Core Enzyme Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America mRNA Vaccine Core Enzyme Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe mRNA Vaccine Core Enzyme Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe mRNA Vaccine Core Enzyme Sales by Country (2020-2025) & (K Units)
 Table 32. Europe mRNA Vaccine Core Enzyme Sales by Country (2026-2031) & (K Units)
 Table 33. Europe mRNA Vaccine Core Enzyme Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe mRNA Vaccine Core Enzyme Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific mRNA Vaccine Core Enzyme Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific mRNA Vaccine Core Enzyme Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific mRNA Vaccine Core Enzyme Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific mRNA Vaccine Core Enzyme Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific mRNA Vaccine Core Enzyme Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America mRNA Vaccine Core Enzyme Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America mRNA Vaccine Core Enzyme Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America mRNA Vaccine Core Enzyme Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America mRNA Vaccine Core Enzyme Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America mRNA Vaccine Core Enzyme Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa mRNA Vaccine Core Enzyme Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa mRNA Vaccine Core Enzyme Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa mRNA Vaccine Core Enzyme Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa mRNA Vaccine Core Enzyme Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa mRNA Vaccine Core Enzyme Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global mRNA Vaccine Core Enzyme Sales (K Units) by Enzyme Type (2020-2025)
 Table 51. Global mRNA Vaccine Core Enzyme Sales (K Units) by Enzyme Type (2026-2031)
 Table 52. Global mRNA Vaccine Core Enzyme Sales Market Share by Enzyme Type (2020-2025)
 Table 53. Global mRNA Vaccine Core Enzyme Sales Market Share by Enzyme Type (2026-2031)
 Table 54. Global mRNA Vaccine Core Enzyme Revenue (US$ Million) by Enzyme Type (2020-2025)
 Table 55. Global mRNA Vaccine Core Enzyme Revenue (US$ Million) by Enzyme Type (2026-2031)
 Table 56. Global mRNA Vaccine Core Enzyme Revenue Market Share by Enzyme Type (2020-2025)
 Table 57. Global mRNA Vaccine Core Enzyme Revenue Market Share by Enzyme Type (2026-2031)
 Table 58. Global mRNA Vaccine Core Enzyme Price (US$/Unit) by Enzyme Type (2020-2025)
 Table 59. Global mRNA Vaccine Core Enzyme Price (US$/Unit) by Enzyme Type (2026-2031)
 Table 60. Global mRNA Vaccine Core Enzyme Sales (K Units) by Application (2020-2025)
 Table 61. Global mRNA Vaccine Core Enzyme Sales (K Units) by Application (2026-2031)
 Table 62. Global mRNA Vaccine Core Enzyme Sales Market Share by Application (2020-2025)
 Table 63. Global mRNA Vaccine Core Enzyme Sales Market Share by Application (2026-2031)
 Table 64. Global mRNA Vaccine Core Enzyme Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global mRNA Vaccine Core Enzyme Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global mRNA Vaccine Core Enzyme Revenue Market Share by Application (2020-2025)
 Table 67. Global mRNA Vaccine Core Enzyme Revenue Market Share by Application (2026-2031)
 Table 68. Global mRNA Vaccine Core Enzyme Price (US$/Unit) by Application (2020-2025)
 Table 69. Global mRNA Vaccine Core Enzyme Price (US$/Unit) by Application (2026-2031)
 Table 70. Thermo Fisher Company Information
 Table 71. Thermo Fisher Description and Business Overview
 Table 72. Thermo Fisher mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Thermo Fisher mRNA Vaccine Core Enzyme Product
 Table 74. Thermo Fisher Recent Developments/Updates
 Table 75. NEB Company Information
 Table 76. NEB Description and Business Overview
 Table 77. NEB mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. NEB mRNA Vaccine Core Enzyme Product
 Table 79. NEB Recent Developments/Updates
 Table 80. TriLink Bio Technologies Company Information
 Table 81. TriLink Bio Technologies Description and Business Overview
 Table 82. TriLink Bio Technologies mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. TriLink Bio Technologies mRNA Vaccine Core Enzyme Product
 Table 84. TriLink Bio Technologies Recent Developments/Updates
 Table 85. Merck Company Information
 Table 86. Merck Description and Business Overview
 Table 87. Merck mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Merck mRNA Vaccine Core Enzyme Product
 Table 89. Merck Recent Developments/Updates
 Table 90. Aldevron Company Information
 Table 91. Aldevron Description and Business Overview
 Table 92. Aldevron mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Aldevron mRNA Vaccine Core Enzyme Product
 Table 94. Aldevron Recent Developments/Updates
 Table 95. Qiagen N.V. Company Information
 Table 96. Qiagen N.V. Description and Business Overview
 Table 97. Qiagen N.V. mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Qiagen N.V. mRNA Vaccine Core Enzyme Product
 Table 99. Qiagen N.V. Recent Developments/Updates
 Table 100. Promega Company Information
 Table 101. Promega Description and Business Overview
 Table 102. Promega mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Promega mRNA Vaccine Core Enzyme Product
 Table 104. Promega Recent Developments/Updates
 Table 105. Roche CustomBiotech Company Information
 Table 106. Roche CustomBiotech Description and Business Overview
 Table 107. Roche CustomBiotech mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Roche CustomBiotech mRNA Vaccine Core Enzyme Product
 Table 109. Roche CustomBiotech Recent Developments/Updates
 Table 110. Takara Bio Inc. Company Information
 Table 111. Takara Bio Inc. Description and Business Overview
 Table 112. Takara Bio Inc. mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Takara Bio Inc. mRNA Vaccine Core Enzyme Product
 Table 114. Takara Bio Inc. Recent Developments/Updates
 Table 115. Novoprotein Company Information
 Table 116. Novoprotein Description and Business Overview
 Table 117. Novoprotein mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Novoprotein mRNA Vaccine Core Enzyme Product
 Table 119. Novoprotein Recent Developments/Updates
 Table 120. Vazyme Company Information
 Table 121. Vazyme Description and Business Overview
 Table 122. Vazyme mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Vazyme mRNA Vaccine Core Enzyme Product
 Table 124. Vazyme Recent Developments/Updates
 Table 125. Hongene Biotech Corporatio Company Information
 Table 126. Hongene Biotech Corporatio Description and Business Overview
 Table 127. Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Product
 Table 129. Hongene Biotech Corporatio Recent Developments/Updates
 Table 130. Yeasen Biotechnology Company Information
 Table 131. Yeasen Biotechnology Description and Business Overview
 Table 132. Yeasen Biotechnology mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Yeasen Biotechnology mRNA Vaccine Core Enzyme Product
 Table 134. Yeasen Biotechnology Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. mRNA Vaccine Core Enzyme Distributors List
 Table 138. mRNA Vaccine Core Enzyme Customers List
 Table 139. mRNA Vaccine Core Enzyme Market Trends
 Table 140. mRNA Vaccine Core Enzyme Market Drivers
 Table 141. mRNA Vaccine Core Enzyme Market Challenges
 Table 142. mRNA Vaccine Core Enzyme Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of mRNA Vaccine Core Enzyme
 Figure 2. Global mRNA Vaccine Core Enzyme Market Value Comparison by Enzyme Type (2020-2031) & (US$ Million)
 Figure 3. Global mRNA Vaccine Core Enzyme Market Share by Enzyme Type: 2024 & 2031
 Figure 4. Capping Enzyme Product Picture
 Figure 5. 2'-O-Methyltransferase Product Picture
 Figure 6. Inorganic Pyrophosphatase Product Picture
 Figure 7. Poly (A) Polymerase Product Picture
 Figure 8. Rnase Inhibitor Product Picture
 Figure 9. RNA Polymerase Product Picture
 Figure 10. Restriction Enzyme Product Picture
 Figure 11. Dnase I Product Picture
 Figure 12. Others Product Picture
 Figure 13. Global mRNA Vaccine Core Enzyme Market Value by Application (2020-2031) & (US$ Million)
 Figure 14. Global mRNA Vaccine Core Enzyme Market Share by Application: 2024 & 2031
 Figure 15. Biopharmaceutical Companies
 Figure 16. Academic and Research Institutions
 Figure 17. Global mRNA Vaccine Core Enzyme Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global mRNA Vaccine Core Enzyme Market Size (2020-2031) & (US$ Million)
 Figure 19. Global mRNA Vaccine Core Enzyme Sales (2020-2031) & (K Units)
 Figure 20. Global mRNA Vaccine Core Enzyme Average Price (US$/Unit) & (2020-2031)
 Figure 21. mRNA Vaccine Core Enzyme Report Years Considered
 Figure 22. mRNA Vaccine Core Enzyme Sales Share by Manufacturers in 2024
 Figure 23. Global mRNA Vaccine Core Enzyme Revenue Share by Manufacturers in 2024
 Figure 24. Global 5 and 10 Largest mRNA Vaccine Core Enzyme Players: Market Share by Revenue in mRNA Vaccine Core Enzyme in 2024
 Figure 25. mRNA Vaccine Core Enzyme Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Global mRNA Vaccine Core Enzyme Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 27. North America mRNA Vaccine Core Enzyme Sales Market Share by Country (2020-2031)
 Figure 28. North America mRNA Vaccine Core Enzyme Revenue Market Share by Country (2020-2031)
 Figure 29. United States mRNA Vaccine Core Enzyme Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Canada mRNA Vaccine Core Enzyme Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Europe mRNA Vaccine Core Enzyme Sales Market Share by Country (2020-2031)
 Figure 32. Europe mRNA Vaccine Core Enzyme Revenue Market Share by Country (2020-2031)
 Figure 33. Germany mRNA Vaccine Core Enzyme Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. France mRNA Vaccine Core Enzyme Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. U.K. mRNA Vaccine Core Enzyme Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Italy mRNA Vaccine Core Enzyme Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Russia mRNA Vaccine Core Enzyme Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Asia Pacific mRNA Vaccine Core Enzyme Sales Market Share by Region (2020-2031)
 Figure 39. Asia Pacific mRNA Vaccine Core Enzyme Revenue Market Share by Region (2020-2031)
 Figure 40. China mRNA Vaccine Core Enzyme Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Japan mRNA Vaccine Core Enzyme Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. South Korea mRNA Vaccine Core Enzyme Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. India mRNA Vaccine Core Enzyme Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Australia mRNA Vaccine Core Enzyme Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. China Taiwan mRNA Vaccine Core Enzyme Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Southeast Asia mRNA Vaccine Core Enzyme Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America mRNA Vaccine Core Enzyme Sales Market Share by Country (2020-2031)
 Figure 48. Latin America mRNA Vaccine Core Enzyme Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico mRNA Vaccine Core Enzyme Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil mRNA Vaccine Core Enzyme Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina mRNA Vaccine Core Enzyme Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Colombia mRNA Vaccine Core Enzyme Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Middle East and Africa mRNA Vaccine Core Enzyme Sales Market Share by Country (2020-2031)
 Figure 54. Middle East and Africa mRNA Vaccine Core Enzyme Revenue Market Share by Country (2020-2031)
 Figure 55. Turkey mRNA Vaccine Core Enzyme Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Saudi Arabia mRNA Vaccine Core Enzyme Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. UAE mRNA Vaccine Core Enzyme Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Global Sales Market Share of mRNA Vaccine Core Enzyme by Enzyme Type (2020-2031)
 Figure 59. Global Revenue Market Share of mRNA Vaccine Core Enzyme by Enzyme Type (2020-2031)
 Figure 60. Global mRNA Vaccine Core Enzyme Price (US$/Unit) by Enzyme Type (2020-2031)
 Figure 61. Global Sales Market Share of mRNA Vaccine Core Enzyme by Application (2020-2031)
 Figure 62. Global Revenue Market Share of mRNA Vaccine Core Enzyme by Application (2020-2031)
 Figure 63. Global mRNA Vaccine Core Enzyme Price (US$/Unit) by Application (2020-2031)
 Figure 64. mRNA Vaccine Core Enzyme Value Chain
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global mRNA Vaccine Raw Materials Market Research Report 2024
Global mRNA Vaccines Therapeutics Market Research Report 2024
Global mRNA Vaccine And Therapeutics Market Insights Forecast to 2030
Global mRNA Cancer Vaccines and Therapeutics Market Insights Forecast to 2030
Global mRNA Synthesis Manufacturing Market Research Report 2024
Global RNA Vaccines Market Insights Forecast to 2030
Messenger RNA Vaccines and Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global mRNA Vaccine Drugs Development Services Market Research Report 2024
mRNA Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global mRNA Therapy Market Research Report 2024
Global mRNA Development and Manufacturing Services Market Research Report 2025
Global mRNA Capping Enzyme Market Research Report 2024
mRNA Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
mRNA Vaccine and Therapeutics Raw Material Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global mRNA Raw Enzyme Market Research Report 2025
Global mRNA Delivery System Market Research Report 2024
Global Livestock mRNA Vaccines Market Research Report 2025
mRNA Vaccines for Infectious Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global mRNA Treatment Market Research Report 2024
Global Veterinary mRNA Vaccines Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions